baber/WOPTO huggingface dataset:
Patent FI-871092-A0 (FI)
Inventor: SULLIVAN LEROY JAMES
IPC: F41A9/73
Filed: 1987-03-12
Abstract: A drum magazine (10) is disclosed for successively feeding a plurality of cartridges (21, 22) to a firearm (11). The magazine has drum shaped housing (12) having a cartridge exit opening (25) at the side of the housing. A rotational cartridge carrying means (16, 17) is disposed within the housing (12) to define a cartridge space (20) between the cartridge carrying means and the inner wall of the housing, for receiving two offset concentric rings of cartridges. A cam means (24) within the housing (12) defines, with the housing, a passage from the cartridge space to the exit opening of the housing means, for urging two offset concentric rings of cartridges (21, 22) alternately together into a single row when cartridges are moved out of the housing.
Patent FI-901325-A0 (FI)
Inventor: JAMES CLAUDE
IPC: A61P31/04
Filed: 1990-03-16
Abstract: New derivatives of formula (I) in which R1=H, halogen, alkyl, alkyloxy, CF3, NH2, alkylamino, dialkylamino, OH, CH, phenyl or phenoxy, Ar=phenyl, naphthyl, pyridyl, quinolyl, isoquinolyl, thienyl, thieno[2,3-b]thienyl or thieno[3,2-b]thienyl (these groups optionally substituted with halogen, alkyl, alkyloxy, CF3, NH2, alkylamino, dialkylamino, OH or CN), p=0, 1 or 2, and A-either Z=valency bond and R2=H B-or Z=valency bond and R2=pyridyl, quinuclidinyl, 3-pyrrolidinyl, 3- or 4-piperidyl (these groups optionally being substituted with alkyl, hydroxyalkyl, phenyl or phenylalkyl) C-or Z=alkylene radical (1 to 4C) and R2=2-, 3- or 4-pyridyl, 3-quinuclidinyl, 2- or 3-pyrrolidinyl, 2-, 3- or 4-piperidyl (optionally substituted with alkyl, hydroxyalkyl, phenyl or phenylalkyl) or R2=CON(R3)(R4) where a) either R3 and R4 form a piperazine optionally substituted with alkyl, hydroxyalkyl, pyridyl, phenyl or phenylalkyl, b) or R3=H, alkyl, phenyl or phenylalkyl, or (CH2)nN(R5) (R6) where 1<n<4 and R5 and R6=H, alkyl, phenyl, phenylalkyl, or R5 and R6 form a morpholine, thiomorpholine, pyrrolidine, piperidine or piperazine ring, (optionally substituted with alkyl, hydroxyalkyl, pyridyl, phenyl, phenylalkyl or phenylcarbonyl), and R4=(CH2)nN(R5)(R6) defined as above, D- or Z=alkylene (1 to 4C) and R2=N(R3) (R4) or N(R5)R6) where R3, R4, R5 and R6 are defined as above in C b), on the understanding that the alkyls contain 1 to 4C in a straight or branched chain and that the invention relates to the racemates, the enantiomers and mixtures thereof, the diastereoisomers, pure or mixed, and the E and Z isomers, as well as to the salts of these products.   <IMAGE> (I)
Patent FI-904371-A0 (FI)
Inventor: KNOP REINHARD
IPC: G01B5/30
Filed: 1990-09-04
Abstract: In a device for the measurement of deformations of an elongated machine part, especially of the scraper beam (5) of a coating device, a strip (9) freely clamped in a straight line is arranged at a distance from the machine part. The strip (9) is mounted elastically deformably or resiliently in the longitudinal direction, and rigidly connected to the machine part only with its clamped ends. A sensor (14), which is rigidly connected to the machine part and measures a change in distance from the strip (9), is arranged between the two ends of the strip (9). 
<IMAGE>
Patent FI-910421-A0 (FI)
Inventor: COLOMBET PIERRE
IPC: C01F17/00
Filed: 1991-01-29
Abstract: Process for the synthesis of binary sulphur compounds, such as rare-earth and transition metal sulphur compounds. 
<??>This process consists in reacting a rare-earth compound, for example oxide or carbonate, or a transition metal oxide with a sulphur carbon compound such as CS2, in a closed vessel at a pressure of between 1 x 10<5> Pa and 150 x 10<5> Pa. 
<??>The products obtained are either rare-earth higher sulphides or rare-earth sesquisulphides.
Patent FI-923458-A0 (FI)
Inventor: ASBEROM THEODROS
IPC: C07D223/32
Filed: 1992-07-31
Abstract: PCT No. PCT/US91/00503 Sec. 371 Date Jul. 29, 1992 Sec. 102(e) Date Jul. 29, 1992 PCT Filed Jan. 31, 1991.Novel benzazepines of the formula I:    <IMAGE>  I  or a pharmaceutically acceptable salt thereof, wherein R represents H, alkyl, allyl or   <IMAGE>   A represents -[CR1R2]n-; n represents 3 or 4; R1 and R2 may be the same or different and each independently represents H, OH, atkyl, alkoxy, phnenyl or substituted phenyl, with the proviso that R1 and R2 on the same carbon atom are not both OH, or R1 and R2 on the same carbon atom together represent=O; G represents H, R3(CO)- or ArNHCO-; R3 represents H, alkyl, alkoxy, phenyl or substituted phenyl; Ar represents phenyl or substituted phenyl; and Y and Z may be the same or different and each is independently selected from H, halo, alkyl, alkoxy or halpalkyl; the pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, useful in the treatment of psychoses, drug dependence, D1 dependent neurological disorder or pain are disclosed.
Patent FI-933084-A0 (FI)
Inventor: DICKS MARTIN EDWARD
IPC: E01F9/615
Filed: 1993-07-05
Abstract: To give advice to a driver of a vehicle of the presence of another vehicle closely ahead, and of misty or foggy conditions. Means (7,C3) able to be charged by light from a vehicle headlight, and a visible signal means (8;13,15) connected to and activated by said chargeable means (7,C3), activates said signal means (8;13,15) for a discrete period of time after said headlight has ceased to illuminate said chargeable means (7,C3) and until said chargeable means (7,C3) has discharged. As a result, a trail of signals is permanently provided behind a lead vehicle to give warning to a vehicle behind of its presence and to a distance that constitutes a safe braking distance. <IMAGE>
Patent FI-933439-A0 (FI)
Inventor: SAMSON GENE
IPC: A61M29/02
Filed: 1993-08-02
Abstract: A single lumen valved balloon catheter assembly is disclosed that consists of a single lumen catheter tube that has a distally located integral balloon and a built-in guidewire that has a distal valve member that may be moved axially to engage and block the distal end of the catheter. The diameter of the guidewire is reduced at its distal end and the diameter of the lumen of the catheter tube distally of the balloon is reduced to below that of the proximal diameter of the balloon so that the axial movement of the guidewire distally is limited.
Patent FI-935199-A0 (FI)
Inventor: ROBERT PIERRE
IPC: C08F4/54
Filed: 1993-11-23
Abstract: Supported solid catalyst usable for the polymerisation and the copolymerisation of conjugated dienes, based on the product of reaction of     A) a solid MgCl2 support,   B) an ether and preferably THF, as swelling agent for the support, C) a metal salt chosen from the metals which have an atomic number between 57 and 71 inclusive or 92 in the Periodic Table of the elements and, if the metal salt is not a halide, D) a halogenating agent chosen from the group consisting of an aluminium halogen compound or a halogen compound not containing aluminium, the reaction solid being free from swelling agent, plus E) an organic aluminium derivative which is obligatory when the halogenating agent is not an aluminium halogen compound and optional when the halogenating agent is an aluminium derivative.   The invention also relates to a process for the preparation of this catalyst.
Patent FI-935464-A0 (FI)
Inventor: FASSBERG JULIANNE
IPC: A61K9/00
Filed: 1993-12-07
Abstract: An aerosol formulation contains mometasone furoate and as propellant 1,1,1,2,3,3,3 and is suitable for treating asthma by nasal or oral administration.
Patent FI-941819-A0 (FI)
Inventor: HOLLIGER NIKLAUS
IPC: B61D1/06
Filed: 1994-04-20
Abstract: Doubledeck coach with entry and exit doors (2) on both sides at both ends, an upper and a lower passenger compartment, with doors to the passenger compartments and wagon-intercommunicating doors (3) at both ends of the coach. The access to the passenger compartments in the lower deck and upper deck (5,(4)) is provided from the entry or exit vestibule (9) through a single access door (6) which is arranged between the entry or exit vestibule (9) and an intermediate floor (10). From the intermediate floor (10), the upper and lower passenger compartments can be reached via a descending stair (8) or an ascending stair (7). The intermediate floor (10) has the function of providing safety and comfort. The safety feature is that the access door is not positioned directly in front of or behind a staircase and the comfort feature is that the ascent from the lower deck (5) to the upper deck is interrupted with this intermediate floor (10). The short descending stair (8) to the passenger compartment in the lower deck (5) is replaced in one design variant with an arcuate, wheelchair-compatible ramp. In an "economy" design, a multi-functional staircase column is provided between the stairs. <IMAGE>
Patent FI-942943-A0 (FI)
Inventor: ARUFFO ALEJANDRO
IPC: C07K14/54
Filed: 1994-06-17
Abstract: Soluble fusion molecules were prepared which contained a CD11a/CD18 specific binding region operatively linked to an immunoglobulin constant region. These molecules particularly include extracellular portions of adhesion molecules such as ICAM-1 and ICAM-2 attached to IgG constant regions. The fusion molecules described are utilized as costimulatory agents for the activation of T cells and in methods for increasing CD4+ T cell proliferative response and IL-2 induction.
Patent FI-950826-A0 (FI)
Inventor: ILM MYOEH
IPC: D21C7/00
Filed: 1995-02-23
Abstract: A screen used in the production of cellulose pulp may be mounted in a digester to minimize traditional screen problems (including clogging) without introducing new problems. The screen comprises a screen plate having a plurality of slots formed in it with an inclination angle, which is 30-60° with respect to the bottom edge of the screen plate. The screen plate may comprise a plurality of parallel screen bars side-by-side, or an integral metal plate with slots formed in it. The slots have a width between 1-5 (e.g. 2-4) millimeters and a spacing between them of 3-9 millimeters.
Patent FI-951849-A0 (FI)
Inventor: STRICKLIN DOUGLAS M
IPC: H04W84/02
Filed: 1995-04-19
Abstract: A method and apparatus for automatically transferring control of a portable radio communication device (101) having an internal processor (108) and a first data port (118) comprise transferring (412, 414) control from the internal processor (108) to an external computer (103), the external computer (103) having a second data port (128). In the portable radio communication device (101) the internal processor (108) detects (406) a signal at the first data port (118), the signal indicating that the external computer (103) is coupled to the portable radio communication device (101) through the first and second data ports (118, 128). In response, the internal processor (108) transfers (412, 414) control of the portable radio communication device (101) from the internal processor (108) to the external computer (103).
Patent FI-956093-A0 (FI)
Inventor: JOENSSON KURT
IPC: C02F3/22
Filed: 1995-12-18
Abstract: PCT No. PCT/SE94/00555 Sec. 371 Date May 1, 1996 Sec. 102(e) Date May 1, 1996 PCT Filed Jun. 8, 1994 PCT Pub. No. WO95/00447 PCT Pub. Date Jan. 5, 1995In the biological purification of sewage water or drinking water, it is known to purify the water in a filter bed of granular filter medium, wherein the filter medium is transported from the bottom of the bed to its upper side with the aid of air, so as to obtain a continuously working filter. It is suggested in accordance with the invention that the amount of filter medium to be transported is divided into two or more parts which are transported in parallel, so as to prevent the flow conditions in the transport tube having a negative effect on the reactivity of the filter bed by decreasing the bacteria strain.
Patent FI-961098-A0 (FI)
Inventor: KONINCKX PHILIPPE ROBERT MARIE
IPC: A61K31/565
Filed: 1996-03-08
Abstract: PCT No. PCT/EP94/02997 Sec. 371 Date Jun. 4, 1996 Sec. 102(e) Date Jun. 4, 1996 PCT Filed Sep. 8, 1994 PCT Pub. No. WO95/07081 PCT Pub. Date Mar. 16, 1995The invention relates to a preparation for substitution therapy and oral contraception comprising at least one progestogen and at least one estrogen in which the estrogen dose varies with a periodicity such that blood loss is substantially avoided, wherein the periodicity is preferably less than 10 days, more preferably less than 7 days, such as preparations containing the progestogen and/or estrogen in an oral, transdermal, parenteral and/or implantable application form.
Patent FI-961147-A0 (FI)
Inventor: GUENTHER WOLFGANG
IPC: C08F8/32
Filed: 1996-03-12
Abstract: Copolymers I carrying functional groups and comprising a) 20-60 mol % of at least one monoethylenically unsaturated C4-C6-dicarboxylic acid or an anhydride thereof, b) 10-70 mol % of at least one oligomer of propene or of a branched 1-olefin of 4 to 10 carbon atoms, having an average molecular weight Mw of from 300 to 5000, and c) 1-50 mol % of at least one monoethylenically unsaturated compound which is copolymerizable with the monomers a) and b), a process for their preparation, oil-soluble reaction products obtainable therefrom by reaction with an amine and the use of said reaction products as additives for lubricants and fuels.
Patent FI-963129-A0 (FI)
Inventor: HANSSON ULF HENRI
IPC: B65B37/00
Filed: 1996-08-09
Abstract: PCT No. PCT/SE95/00109 Sec. 371 Date Jun. 20, 1995 Sec. 102(e) Date Jun. 20, 1995 PCT Filed Feb. 6, 1995 PCT Pub. No. WO95/21768 PCT Pub. Date Aug. 14, 1995The invention relates to a device for filling with high accuracy a finely divided powdered medicament having a particle size smaller than 10  mu m into cavities having a size corresponding to the volume of powder to be filled, wherein said device comprises oscillating and rotating means for breaking down aggregates formed in the finely divided powdered medicament and filling and for compacting it in said cavities. The invention also includes a method of filling with high accuracy of a finely divided powdered medicament having a particle size smaller than 10  mu m and to fill said finely divided powdered medicament into cavities, wherein the finely divided powdered medicament is transported and compacted in said cavities by oscillating and rotating means.
Patent FI-963272-A0 (FI)
Inventor: BITONTI ALAN JOSEPH
IPC: A61P35/00
Filed: 1996-08-21
Abstract: The present invention relates to novel indole derivatives useful in down-regulating estrogen receptor expression. Also included are methods for the treatment of neoplasms or of controlling the growth of a neoplasm in a patient afflicted with a neoplastic disease, especially estrogen-dependent neoplasms such as those associated with breast, ovarian and cervical tissue. Another embodiment of the present invention is a method of prophylactically treating a patient at risk of developing a neoplastic disease state. Also provided is a method for treating autoimmune diseases. Also included are pharmaceutical compositions of the novel indole derivatives.
Patent FI-963558-A0 (FI)
Inventor: ASPEHAUG NILS
IPC: E02D27/42
Filed: 1996-09-10
Abstract: PCT No. PCT/NO95/00055 Sec. 371 Date Sep. 12, 1996 Sec. 102(e) Date Sep. 12, 1996 PCT Filed Mar. 13, 1995 PCT Pub. No. WO95/25213 PCT Pub. Date Sep. 21, 1995A foundation for masts, posts, pillars, etc., wherein the foundation has a foundation tube (3) which is lowered into a pre-drilled hole (2) in the ground (1), where the pre-drilled hole has a diameter larger than the diameter of the tube (3) and where at least the space between tube (3) and ground (1) is filled with a casting mixture (8), e.g. concrete, a tube (3) is used which is designed with perforations (4) in its lower area. The foundation tube (3) is equipped with a coating which gives the tube protection against corrosion, and possibly also an electrical insulation. The coatings can have a rough surface in order to create the best possible adhesion to the casting mixture. In order to ensure that the coated foundation tube (3) is safely lowered into the hole, it is first lined with a casing (13), which is removed during or immediately after the casting.
Patent FI-981825-A0 (FI)
Inventor: KOJO TEPPO
IPC: B65H19/00
Filed: 1998-08-26
Abstract: The invention relates to a method in sequential winding stations which are in a production line processing the web at successive stages. In the method the paper web issuing from a paper machine (PK) is reeled in a reel-up (KR 1 ) around a reel spool (T 1 ) to form a reel, the paper web is unwound in an unwind (AR) from the reel to the finishing machine (JK) for paper, and the paper web passed through the finishing machine (JK) for paper is reeled in a reel-up (KR 2 ) around a reel spool (T 2 ) to form a reel. At least the reel spools (T 1 ) used in the area between the reel-up (KR 1 ) of the paper machine (PK) and an unwind thereafter, have different dimensions, advantageously larger diameters, than the reel spools (T 2 ) used later in the production line.
Patent AP-9300561-A0 (AP)
Title: Antibiotic compounds.
Inventor: JUNG FREDRIC HENRI
IPC: A61K31/397
Filed: 1993-08-26
Abstract: The present invention relates to carbapenems and provides a compound of the formula (i). Process for their preparation, intermediates in their preparation, their use as therapeutic agents and pharmaceutical compositions containing them are also described.
Patent IL-65310-A0 (IL)
Title: 9-(2-(3-indolyl)ethyl)-1-oxa-4,9-diazaspiro(5,5)undecan-3-ones,their preparation and pharmaceutical compositions containing them
IPC: A61K31/535
Filed: 1982-03-22
Abstract: Compounds useful in the prevention and/or treatment of hypertension, congestive heart failure, arrhythmia, migraine, vasospastic disorders, and asthma are represented by the formula   <IMAGE> (I) wherein: R, R1, R2, R3, and R4 are independently hydrogen or lower alkyl of one to four carbon atoms; and R5 and R6 are independently hydrogen, lower alkyl of one to four carbon atoms or lower alkoxy of one to four carbon atoms; and the pharmaceutically acceptable acid addition salts thereof.
Patent IL-71522-A0 (IL)
Title: N-sulphenylated phenethylsulphonamides,their preparation and their use as pesticides
IPC: C07C67/00
Filed: 1984-04-12
Abstract: 1. N-Sulphenylated phenethylsulphonamides of the formula (I)  see diagramm : EP0122553,P11,F1  in which R**1 represents hydrogen or chlorine, R**2 represents alkyl with 1 to 4 carbon atoms, alkenyl with 2 to 5 carbon atoms, alkoxyalkyl or alkylthioalkyl with 1 to 4 carbon atoms per alkyl part, cycloalkyl which has 4 to 6 carbon atoms and is optionally mono- to trisubstituted by methyl or ethyl, aralkyl with 1 or 2 carbon atoms in the alkyl part and 6 or 10 carbon atoms in the aryl part, phenyl or naphthyl, the ring in the aralkyl, the phenyl ring or the naphthyl ring being optionally mono-to octasubstituted by identical or different substituents selected from fluorine, chlorine, bromine, nitro, cyano, methyl, trifluoromethyl, methoxy, ethoxy, propoxy, methylthio, ethylthio or propylthio, and X represents fluorine or chlorine.
Patent IL-85608-A0 (IL)
Title: High drug:lipid formulations of liposomal-antineoplastic agents
IPC: A61K45/08
Filed: 1988-03-02
Abstract: A method for encapsulation of antineoplastic agents in liposomes is provided, having preferably a high drug:lipid ratio. Liposomes may be made by a process that loads the drug by an active mechanism using a transmembrane ion gradient, preferably a transmembrane pH gradient. Using this technique, trapping efficiencies approach 100%, and liposomes may be loaded with drug immediately prior to use, eliminating stability problems related to drug retention in the liposomes. Drug:lipid ratios employed are about 3-80 fold higher than for traditional liposome preparations, and the release rate of the drug from the liposomes is reduced. An assay method to determine free antineoplastic agents in a liposome preparation is also disclosed.
Patent IL-97932-A0 (IL)
Title: Proteins and polypeptides having substituted cysteine residues and pharmaceutical compositions containing the same
IPC: C07K1/107
Filed: 1991-04-24
Abstract: The present invention relates to physiologically-active derivatized natural and recombinant mammalian and human proteins and polypeptides. The invention provides chemical methods for derivatizing natural and recombinantly-derived proteins or polypeptides containing cysteine residues, either naturally or through site specific mutageneses. The pharmaceutical compositions containing said derivatized proteins and/or polypeptides are formulated to provide stable, long-acting compositions of such proteins and/or polypeptides, previously difficult to achieve.
Patent AU-PO530997-A0 (AU)
Title: Surgical aid for connective tissue grafting and method for employing same
IPC: A61F2/08
Filed: 1997-02-25
Abstract: A device for use in ligament grafting includes a holder for receiving a ligament graft. A sheath is mounted over the holder in an expanded diameter state. The ligament graft is removed from the hollow body with the sheath so that the ligament graft is captured in the sheath in a reduced diameter state and a substantial length of the sheath extends from opposite ends of the graft.
Patent FI-20030329-A0 (FI)
Inventor: LARSSON THOMAS
IPC: F16L41/03
Filed: 2003-03-03
Abstract: A manifold (1) comprises a body (2) with a plurality of branch fittings (3) diverging therefrom. The inner surface of the body (2) is conical such that the inner cross-sectional area of the body (2) decreases in the direction of flow. The manifold (1) is particularly well suited for use in tap water systems. The manifold (1) can be manufactured e.g. from polyphenyl sulfone PPSU, polysulphone PSU, polyvinylidene fluoride PVDF, glass fiber reinforced polyamide PA, or cross-linked polyolefin plastic.
Patent IL-116409-A0 (IL)
Title: Process for the recovery of alumina and silica
IPC: C01F7/22
Filed: 1995-12-15
Abstract: PCT No. PCT/IL96/00179 Sec. 371 Date Dec. 15, 1998 Sec. 102(e) Date Dec. 15, 1998 PCT Filed Dec. 12, 1996 PCT Pub. No. WO97/22554 PCT Pub. Date Jun. 26, 1997A process for the simultaneous recovery of substantially pure alumina and silica from an aluminosilicate. The process comprises the following steps: (i) heating the aluminosilicate with hydrated CaCl2 to obtain calcium-alumino-silicate and calcium-aluminate products, wherein the CaCl2 is substantially free of MgCl2; (ii) leaching the products with HCl to form a solution comprising AlCl3 and CaCl2, and insoluble silica; (iii) separating the insoluble silica from the solution; and (iv) crystallizing AlCl3 from the solution and recovering the alumina from the crystallized AlCl3. The process may further comprise the following steps: (v) substantially removing MgCl2 from the CaCl2 solution of step (iv); and (vi) recycling the CaCl2 solution for use in step (i).
Patent IL-123377-A0 (IL)
Title: Device for the vertical arrangement of a pole- or post-like object
IPC: E04H12/22
Filed: 1996-08-22
Abstract: The invention concerns a device for the vertical arrangement of a pole or post-like object (4) on a securing device (6) disposed at the ground end. The device comprises a substantially cylindrical, elongate mounting mandrel (10) which can be inserted into an accommodating bore (12) in the underside of the pole or post-like object (4). The device further comprises a support plate (16) from whose plane the mounting mandrel (10) extends upwards and on which the underside (14) of the pole or post-like object (4) rests. At least one securing projection (18) protrudes upwards from the support plate (16) and penetrates the material of the pole or post-like object (4). The mounting mandrel (10) is substantially thinner than the accommodating bore (12) in the underside of the pole or post-like object (4) such that there is considerable play between the journal or mounting mandrel (10) and the bore (12) surrounding the mandrel in the underside of the pole or post. Owing to this play, the pole or post (4) can be mounted on the mounting mandrel (10) such that the pole or post is tilted or inclined within a given angular range. This inclined or tilted position permits compensation of any positions of the securing device (6) disposed at the ground end which are lopsided relative to the vertical.